Literature DB >> 3100416

von Willebrand disease.

T S Zimmerman, Z M Ruggeri.   

Abstract

von Willebrand disease (vWD) is a bleeding disorder characterized by a complex hemostatic defect. Abnormal platelet function, usually reflected by a prolonged bleeding time, is the result of a quantitative or qualitative defect of von Willebrand factor (vWF). A secondary deficiency of factor VIII procoagulant protein (factor VIII) may occur leading to a coagulation defect as well. These two glycoprotein macromolecules circulate as a complex in plasma. This article will review current understanding of structures and functions of vWF factor and factor VIII as they relate to the pathogenesis, diagnosis, classification and therapy of vWD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100416     DOI: 10.1016/s0046-8177(87)80332-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

2.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.

Authors:  K M Brinkhous; U Hedner; J B Garris; V Diness; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Two sisters with multiple sclerosis, lamellar ichthyosis, beta thalassaemia minor and a deficiency of factor VIII.

Authors:  R Capra; F Mattioli; B Kalman; N Marcianò; A Berenzi; A Benetti
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

5.  Autosomal dominant postaxial polydactyly, nail dystrophy, and dental abnormalities map to chromosome 4p16, in the region containing the Ellis-van Creveld syndrome locus.

Authors:  T D Howard; A E Guttmacher; W McKinnon; M Sharma; V A McKusick; E W Jabs
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

Review 6.  Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.

Authors:  Zaverio M Ruggeri; Alessandro Zarpellon; James R Roberts; Richard A Mc Clintock; Hua Jing; G Loredana Mendolicchio
Journal:  Thromb Haemost       Date:  2010-10-12       Impact factor: 5.249

7.  Inheritance and prevalence of von Willebrand's disease severe form in a Brazilian population.

Authors:  R R Fischer; C Lerner; E Bandinelli; A S Fonseca; I Roisenberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

Authors:  D A Bellinger; T C Nichols; M S Read; R L Reddick; M A Lamb; K M Brinkhous; B L Evatt; T R Griggs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  ADAMTS proteases in cardiovascular physiology and disease.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Open Biol       Date:  2020-12-23       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.